10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 230 filers reported holding 10X GENOMICS INC in Q3 2022. The put-call ratio across all filers is 0.78 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $979,646 | -28.6% | 23,749 | -3.3% | 0.01% | -27.3% |
| Q2 2023 | $1,371,207 | +10.9% | 24,556 | +10.8% | 0.01% | 0.0% |
| Q1 2023 | $1,236,251 | +58.1% | 22,159 | +3.3% | 0.01% | +37.5% |
| Q4 2022 | $781,857 | +19.6% | 21,456 | -6.6% | 0.01% | +14.3% |
| Q3 2022 | $654,000 | -36.5% | 22,972 | +0.9% | 0.01% | -30.0% |
| Q2 2022 | $1,030,000 | -37.5% | 22,756 | +5.0% | 0.01% | -23.1% |
| Q1 2022 | $1,648,000 | -47.2% | 21,670 | +3.3% | 0.01% | -45.8% |
| Q4 2021 | $3,124,000 | +3.1% | 20,969 | +0.7% | 0.02% | -4.0% |
| Q3 2021 | $3,031,000 | -25.1% | 20,817 | +0.7% | 0.02% | -24.2% |
| Q2 2021 | $4,049,000 | +21.0% | 20,679 | +11.8% | 0.03% | +13.8% |
| Q1 2021 | $3,347,000 | +34.3% | 18,489 | +5.0% | 0.03% | +26.1% |
| Q4 2020 | $2,493,000 | – | 17,605 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 708,528 | $29,226,780 | 100.00% |
| Meritech Capital Associates V L.L.C. | 494,236 | $20,387,235 | 6.48% |
| Sands Capital Ventures, LLC | 481,770 | $19,873,013 | 5.88% |
| Decheng Capital Management III (Cayman), LLC | 359,554 | $14,831,603 | 4.95% |
| Iron Triangle Partners LP | 666,945 | $27,511,481 | 4.02% |
| Endurant Capital Management LP | 71,044 | $2,930,565 | 2.63% |
| Brown Capital Management | 3,081,105 | $127,095,581 | 1.95% |
| RTW INVESTMENTS, LP | 1,519,956 | $62,698,185 | 1.32% |
| Parametrica Management Ltd | 15,300 | $631,125 | 1.06% |
| Capital Impact Advisors, LLC | 14,821 | $611,366 | 1.02% |